Related Experiment Videos

Low responsiveness to Candida antigens in kidney transplant recipients

C M Ausiello1, G C Spagnoli, G Sconocchia

  • 1Istituto CNR Tipizzazione Tissutale, II Università, Rome, Italy.

Microbiologica
|October 1, 1991
PubMed

Insights

Kidney transplant patients show reduced immune response to Candida albicans mannoprotein (MP), especially years after transplant. Interleukin-2 (IL-2) partially restored this immune response in some patients.

Area of Science:

  • Immunology
  • Transplantation
  • Mycology

Background:

  • Kidney transplant recipients on immunosuppression are susceptible to infections from commensal microorganisms like Candida albicans.
  • Candida albicans mannoprotein (MP) is a key antigen involved in immune responses.

Purpose of the Study:

  • To assess the specific immune responsiveness to C. albicans mannoprotein (MP) in kidney transplanted patients.
  • To analyze how transplant age affects immune responsiveness to MP.
  • To investigate the role of Interleukin-2 (IL-2) in restoring MP-specific immune responses.

Main Methods:

  • Studied 44 kidney transplanted patients and healthy controls.
  • Measured immune responsiveness using peripheral blood mononuclear cells (PBMC) stimulated with MP.
  • Categorized patients into groups based on transplant age (1-12 months, 1-3 years, 4-6 years).
  • Assessed proliferation and response to mitogens (PHA, SEB) and IL-2 addition.

Main Results:

  • Kidney transplant patients in later transplant stages (1-3 and 4-6 years) exhibited significantly lower PBMC responsiveness to MP.
  • Addition of exogenous IL-2 restored MP-induced proliferation in approximately 50% of the studied patients.
  • Responsiveness to general mitogenic stimulation (PHA, SEB) remained normal across all transplanted patients.
  • No correlation was found between MP hyporesponsiveness and documented C. albicans infections.

Conclusions:

  • Long-term kidney transplant recipients may have a diminished specific immune response to Candida albicans mannoprotein.
  • IL-2 administration shows potential in partially restoring T-cell function against fungal antigens in this population.
  • The observed hyporesponsiveness to MP does not directly correlate with the incidence of C. albicans infections in these patients.

Related Concept Videos